IPG grabs $10M for device implant cost-management system

IPG pulled in a $10 million Series C to help fuel development and growth of its software designed, in part, to help manage device implant use and spending. Camden Partners led the round, along with participation from existing investor Sequoia Capital. IPG's platform generates data regarding the overall cost and quality of implant procedures. Execs frame the concept as a novel way to help control costs by linking insurers, providers, hospitals and device makers. IPG, based in Alpharetta, GA, has raised $50 million to date. Item